Dendritic cell plasticity in tumor-conditioned skin: CD14+ cells at the cross-roads of immune activation and suppression
Tumors abuse myeloid plasticity to re-direct dendritic cell (DC) differentiation from T cell stimulatory subsets to immune suppressive subsets that can interfere with antitumor immunity. Lined by a dense network of easily accessible DC the skin is a preferred site for the delivery of DC-targeted vac...
Main Authors: | Rieneke evan de Ven, Jelle Jan Lindenberg, Dinja eOosterhoff, Tanja Denise De Gruijl |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00403/full |
Similar Items
-
What’s in a name? Some early and current issues in dendritic cell nomenclature
by: Ken eShortman, et al.
Published: (2015-05-01) -
Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses
by: Dorian A. Stolk, et al.
Published: (2020-05-01) -
Between biology and medicine: perspectives on the use of dendritic cells in anticancer therapy
by: Agnieszka Szczygieł, et al.
Published: (2017-11-01) -
Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors
by: Maud Plantinga, et al.
Published: (2019-02-01) -
CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine
by: Maud Plantinga, et al.
Published: (2021-07-01)